{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:53:40Z","timestamp":1790373220621,"version":"4.1.0"},"reference-count":247,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"abstract":"<jats:p>Parkinson\u2019s disease (PD) and other synucleinopathies are characterized by the aggregation and deposition of alpha-synuclein (<jats:italic>\u03b1<\/jats:italic>-syn) in brain cells, forming insoluble inclusions such as Lewy bodies (LBs) and Lewy neurites (LNs). The aggregation of <jats:italic>\u03b1<\/jats:italic>-syn is a complex process involving the structural conversion from its native random coil to well-defined secondary structures rich in <jats:italic>\u03b2<\/jats:italic>-sheets, forming amyloid-like fibrils. Evidence suggests that intermediate species of <jats:italic>\u03b1<\/jats:italic>-syn aggregates formed during this conversion are responsible for cell death. However, the molecular events involved in <jats:italic>\u03b1<\/jats:italic>-syn aggregation and its relationship with disease onset and progression remain not fully elucidated. Additionally, the clinical and pathological heterogeneity observed in various synucleinopathies has been highlighted. Liquid\u2013liquid phase separation (LLPS) and condensate formation have been proposed as alternative mechanisms that could underpin <jats:italic>\u03b1<\/jats:italic>-syn pathology and contribute to the heterogeneity seen in synucleinopathies. This review focuses on the role of the cellular environment in <jats:italic>\u03b1<\/jats:italic>-syn conformational rearrangement, which may lead to pathology and the existence of different <jats:italic>\u03b1<\/jats:italic>-syn conformational strains with varying toxicity patterns. The discussion will include cellular stress, abnormal LLPS formation, and the potential role of LLPS in <jats:italic>\u03b1<\/jats:italic>-syn pathology.<\/jats:p>","DOI":"10.3389\/fnmol.2024.1494218","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T05:12:01Z","timestamp":1729660321000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Liquid\u2013liquid phase separation and conformational strains of \u03b1-Synuclein: implications for Parkinson\u2019s disease pathogenesis"],"prefix":"10.3389","volume":"17","author":[{"given":"Eva D.","family":"Ruiz-Ortega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wilkaniec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Adamczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1016\/j.bpj.2017.08.027","article-title":"Modification of C terminus provides new insights into the mechanism of \u03b1-Synuclein aggregation","volume":"113","author":"Afitska","year":"2017","journal-title":"Biophys. J."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cell.2018.12.035","article-title":"Considerations and challenges in studying liquid-liquid phase separation and biomolecular condensates","volume":"176","author":"Alberti","year":"2019","journal-title":"Cell"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"8088","DOI":"10.1038\/ncomms9088","article-title":"Liquid demixing of intrinsically disordered proteins is seeded by poly (ADP-ribose)","volume":"6","author":"Altmeyer","year":"2015","journal-title":"Nat. Commun."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/mds.25421","article-title":"Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson\u2019s disease","volume":"28","author":"Appel-Cresswell","year":"2013","journal-title":"Mov. Disord."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41589-024-01551-2","article-title":"O-GlcNAc forces an \u03b1-synuclein amyloid strain with notably diminished seeding and pathology","volume":"20","author":"Balana","year":"2024","journal-title":"Nat. Chem. Biol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.cell.2016.06.010","article-title":"Compositional control of phase-separated cellular bodies","volume":"166","author":"Banani","year":"2016","journal-title":"Cell"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature10324","article-title":"\u03b1-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation","volume":"477","author":"Bartels","year":"2011","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neuron.2019.10.010","article-title":"Amyloid-Beta (A\u03b2) plaques promote seeding and spreading of alpha-Synuclein and tau in a mouse model of Lewy body disorders with A\u03b2 pathology","volume":"105","author":"Bassil","year":"2020","journal-title":"Neuron"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20192193","article-title":"\u03b1-Synuclein modulates tau spreading in mouse brains","volume":"218","author":"Bassil","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00401-017-1755-1","article-title":"Alpha-synuclein oligomers: a new hope","volume":"134","author":"Bengoa-Vergniory","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/bph.13748","article-title":"Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases","volume":"175","author":"Berger","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1073\/pnas.0407146102","article-title":"Release of long-range tertiary interactions potentiates aggregation of natively unstructured \u03b1-synuclein","volume":"102","author":"Bertoncini","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00401-006-0104-6","article-title":"\u03b1-Synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers","volume":"112","author":"Beyer","year":"2006","journal-title":"Acta Neuropathol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s12035-012-8330-5","article-title":"Alpha-Synuclein posttranslational modification and alternative splicing as a trigger for neurodegeneration","volume":"47","author":"Beyer","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10048-008-0124-6","article-title":"Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease","volume":"9","author":"Beyer","year":"","journal-title":"Neurogenetics"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10048-007-0106-0","article-title":"Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases","volume":"9","author":"Beyer","year":"","journal-title":"Neurogenetics"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.molcel.2020.04.015","article-title":"When separation causes activation: biophysical control of bulk autophagy initiation","volume":"78","author":"Bhattacharya","year":"2020","journal-title":"Mol. Cell"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1039\/C7CC09597J","article-title":"Multitude NMR studies of \u03b1-synuclein familial mutants: probing their differential aggregation propensities","volume":"54","author":"Bhattacharyya","year":"2018","journal-title":"Chem. Commun."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.4103\/1673-5374.371345","article-title":"\u03b1-Synuclein oligomers and fibrils: partners in crime in synucleinopathies","volume":"18","author":"Bigi","year":"2023","journal-title":"Neural Regen. Res."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e2200086","DOI":"10.1002\/bies.202200086","article-title":"Amyloid fibrils act as a reservoir of soluble oligomers, the main culprits in protein deposition diseases","volume":"44","author":"Bigi","year":"2022","journal-title":"BioEssays"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3390\/life11050431","article-title":"Exploring the release of toxic oligomers from \u03b1-Synuclein fibrils with antibodies and STED microscopy","volume":"11","author":"Bigi","year":"2021","journal-title":"Life"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"9893","DOI":"10.1021\/ja0618649","article-title":"Interaction of \u03b1-Synuclein with divalent metal ions reveals key differences: a link between structure, binding specificity and fibrillation enhancement","volume":"128","author":"Binolfi","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2021.666585","article-title":"\u03b1-Synuclein: an all-inclusive trip around its structure, influencing factors and applied techniques","volume":"9","author":"Bisi","year":"2021","journal-title":"Front. Chem."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1083\/jcb.200507002","article-title":"p62\/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death","volume":"171","author":"Bj\u00f8rk\u00f8y","year":"2005","journal-title":"J. Cell Biol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.tcb.2018.02.004","article-title":"Protein phase separation: a new phase in cell biology","volume":"28","author":"Boeynaems","year":"2018","journal-title":"Trends Cell Biol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.sbi.2020.09.004","article-title":"How do intrinsically disordered protein regions encode a driving force for liquid\u2013liquid phase separation?","volume":"67","author":"Borcherds","year":"2021","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1038\/ncomms3575","article-title":"Structural and functional characterization of two alpha-synuclein strains","volume":"4","author":"Bousset","year":"2013","journal-title":"Nat. Commun."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1093\/brain\/awz172","article-title":"Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson\u2019s disease","volume":"142","author":"Brahmachari","year":"2019","journal-title":"Brain"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"7671","DOI":"10.1073\/pnas.1315346111","article-title":"Solution conditions determine the relative importance of nucleation and growth processes in \u03b1-synuclein aggregation","volume":"111","author":"Buell","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1093\/brain\/awad150","article-title":"Advances in understanding the function of alpha-synuclein: implications for Parkinson's disease","volume":"146","author":"Calabresi","year":"2023","journal-title":"Brain J. Neurol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1046\/j.1471-4159.2001.00021.x","article-title":"The solubility of \u03b1-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson\u2019s disease","volume":"76","author":"Campbell","year":"2001","journal-title":"J. Neurochem."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40035-019-0181-9","article-title":"Effect of the micro-environment on \u03b1-synuclein conversion and implication in seeded conversion assays","volume":"9","author":"Candelise","year":"2020","journal-title":"Transl. Neurodegen."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41594-019-0248-4","article-title":"Cryo-EM structures of four polymorphic TDP-43 amyloid cores","volume":"26","author":"Cao","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.neulet.2014.01.009","article-title":"Alpha-synuclein transcript isoforms in three different brain regions from Parkinson\u2019s disease and healthy subjects in relation to the SNCA rs356165\/rs11931074 polymorphisms","volume":"562","author":"Cardo","year":"2014","journal-title":"Neurosci. Lett."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1038\/s41467-021-21937-3","article-title":"The release of toxic oligomers from \u03b1-synuclein fibrils induces dysfunction in neuronal cells","volume":"12","author":"Cascella","year":"2021","journal-title":"Nat. Commun."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"18147","DOI":"10.1039\/C7CP03432F","article-title":"Room-temperature in-cell EPR spectroscopy: alpha-Synuclein disease variants remain intrinsically disordered in the cell","volume":"19","author":"Cattani","year":"2017","journal-title":"Phys. Chem. Chem. Phys."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1042\/BJ20111924","article-title":"Toxic prefibrillar \u03b1-synuclein amyloid oligomers adopt a distinctive antiparallel \u03b2-sheet structure","volume":"443","author":"Celej","year":"2012","journal-title":"Biochem. J."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"E1994","DOI":"10.1073\/pnas.1421204112","article-title":"Structural characterization of toxic oligomers that are kinetically trapped during \u03b1-synuclein fibril formation","volume":"112","author":"Chen","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1021\/acs.molpharmaceut.2c00548","article-title":"Structure-based discovery of small-molecule inhibitors of the autocatalytic proliferation of \u03b1-Synuclein aggregates","volume":"20","author":"Chia","year":"2023","journal-title":"Mol. Pharm."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/s41593-022-01140-3","article-title":"Pathological structural conversion of \u03b1-synuclein at the mitochondria induces neuronal toxicity","volume":"25","author":"Choi","year":"2022","journal-title":"Nat. Neurosci."},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba1193","article-title":"Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological \u03b1-synuclein","volume":"6","author":"Chung","year":"2020","journal-title":"Advances"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1097\/NEN.0000000000000018","article-title":"Confluence of \u03b1-Synuclein, tau, and \u03b2-amyloid pathologies in dementia with Lewy bodies","volume":"72","author":"Colom-Cadena","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/mds.27296","article-title":"New developments in genetic rat models of Parkinson\u2019s disease","volume":"33","author":"Creed","year":"2018","journal-title":"Mov. Disord."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neuroscience.2020.04.032","article-title":"Enhanced susceptibility of PINK1 knockout rats to \u03b1-Synuclein fibrils","volume":"437","author":"Creed","year":"2020","journal-title":"Neuroscience"},{"key":"ref45","first-page":"79","article-title":"Structural characteristics of \u03b1-Synuclein oligomers","volume-title":"Intern. Rev. Cell Molecul. Biol.","author":"Cremades","year":"2017"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","article-title":"Direct observation of the interconversion of normal and toxic forms of \u03b1-synuclein","volume":"149","author":"Cremades","year":"2012","journal-title":"Cell"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.nbd.2017.07.009","article-title":"The contribution of biophysical and structural studies of protein self-assembly to the design of therapeutic strategies for amyloid diseases","volume":"109","author":"Cremades","year":"2018","journal-title":"Neurobiology of disease"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1038\/s41467-024-47585-x","article-title":"Pharmacological inhibition of \u03b1-synuclein aggregation within liquid condensates","volume":"15","author":"Dada","year":"2024","journal-title":"Nat. Commun."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"118984","DOI":"10.1016\/j.bbamcr.2021.118984","article-title":"Combating deleterious phase transitions in neurodegenerative disease","volume":"1868","author":"Darling","year":"2021","journal-title":"Cell Res."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"22262","DOI":"10.1074\/jbc.M110.202937","article-title":"Structural and morphological characterization of aggregated species of \u03b1-Synuclein induced by docosahexaenoic acid","volume":"286","author":"De Franceschi","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.bbamem.2011.09.008","article-title":"Folding and misfolding of alpha-synuclein on membranes","volume":"1818","author":"Dikiy","year":"2012","journal-title":"Biomembranes"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"105696","DOI":"10.1016\/j.nbd.2022.105696","article-title":"Extracellular alpha-synuclein: sensors, receptors, and responses","volume":"168","author":"Domingues","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21228645","article-title":"The role of \u03b1-synuclein oligomers in parkinson\u2019s disease","volume":"21","author":"Du","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1038\/s41591-024-03101-8","article-title":"Target engagement and immunogenicity of an active immunotherapeutic targeting pathological \u03b1-synuclein: a phase 1 placebo-controlled trial","volume":"30","author":"Eijsvogel","year":"2024","journal-title":"Nat. Med."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1046\/j.1432-1327.1998.2580157.x","article-title":"The N\u2010terminal region of non\u2010A\u03b2 component of Alzheimer's disease amyloid is responsible for its tendency to assume \u03b2\u2010sheet and aggregate to form fibrils","volume":"258","author":"El-Agnaf","year":"1998","journal-title":"Eur. J. Biochem."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"7160","DOI":"10.1074\/jbc.REV118.001188","article-title":"Matter over mind: liquid phase separation and neurodegeneration","volume":"294","author":"Elbaum-Garfinkle","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4103\/1735-1995.181989","article-title":"Alpha-synuclein structure, functions, and interactions","volume":"21","author":"Emamzadeh","year":"2016","journal-title":"J. Res. Med. Sci."},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33252-6","article-title":"Small soluble \u03b1-synuclein aggregates are the toxic species in Parkinson's disease","volume":"13","author":"Emin","year":"2022","journal-title":"Communications"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/acn3.338","article-title":"Alpha\u2010synucleinRT\u2010QuICin theCSFof patients with alpha\u2010synucleinopathies","volume":"3","author":"Fairfoul","year":"2016","journal-title":"Annals Clin. Transl. Neurol."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41531-019-0103-7","article-title":"Parkinson's disease: proteinopathy or lipidopathy?","volume":"6","author":"Fanning","year":"2020","journal-title":"NPJ Parkinsons Dis."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.3390\/molecules23071531","article-title":"\u03b1-Synuclein and polyunsaturated fatty acids: molecular basis of the interaction and implication in neurodegeneration","volume":"23","author":"Fecchio","year":"2018","journal-title":"Molecules"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"10328","DOI":"10.1073\/pnas.1604645113","article-title":"Mutations associated with familial Parkinson\u2019s disease alter the initiation and amplification steps of \u03b1-synuclein aggregation","volume":"113","author":"Flagmeier","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"104813","DOI":"10.1016\/j.nbd.2020.104813","article-title":"Disease progression and prognostic factors in multiple system atrophy: a prospective cohort study","volume":"139","author":"Foubert-Samier","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41586-020-1977-6","article-title":"Phase separation organizes the site of autophagosome formation","volume":"578","author":"Fujioka","year":"2020","journal-title":"Nature"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1126\/science.aan6160","article-title":"Structural basis of membrane disruption and cellular toxicity by \u03b1-synuclein oligomers","volume":"358","author":"Fusco","year":"2017","journal-title":"Science"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"106736","DOI":"10.1016\/j.bpc.2021.106736","article-title":"Intermediates of \u03b1-synuclein aggregation: implications in Parkinson\u2019s disease pathogenesis","volume":"281","author":"Gadhe","year":"2022","journal-title":"Biophys. Chem."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1021\/acschemneuro.9b00527","article-title":"Role of \u03b1-Synuclein regions in nucleation and elongation of amyloid Fiber assembly","volume":"11","author":"Gallardo","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"7065","DOI":"10.1073\/pnas.1601899113","article-title":"Chemical properties of lipids strongly affect the kinetics of the membrane-induced aggregation of \u03b1-synuclein","volume":"113","author":"Galvagnion","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.ajpath.2012.11.018","article-title":"Axonopathy in an \u03b1-Synuclein transgenic model of Lewy body disease is associated with extensive accumulation of C-terminal\u2013truncated \u03b1-Synuclein","volume":"182","author":"Games","year":"2013","journal-title":"Am. J. Pathol."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/genes9020063","article-title":"Alternative splicing of alpha- and Beta-Synuclein genes plays differential roles in Synucleinopathies","volume":"9","author":"G\u00e1mez-Valero","year":"2018","journal-title":"Genes"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1017\/S0033583516000172","article-title":"Secondary nucleation of monomers on fibril surface dominates \u03b1-synuclein aggregation and provides autocatalytic amyloid amplification","volume":"50","author":"Gaspar","year":"2017","journal-title":"Q. Rev. Biophys."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"e90659","DOI":"10.1371\/journal.pone.0090659","article-title":"Unlike twins: an NMR comparison of two \u03b1-Synuclein polymorphs featuring different toxicity","volume":"9","author":"Gath","year":"2014","journal-title":"PLoS One"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"6925","DOI":"10.1021\/bi400999d","article-title":"The Parkinson\u2019s disease-associated H50Q mutation accelerates \u03b1-Synuclein aggregation in vitro","volume":"52","author":"Ghosh","year":"2013","journal-title":"Biochemistry"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/pro.3859","article-title":"The metastable states of proteins","volume":"29","author":"Ghosh","year":"2020","journal-title":"Protein science: a publication of the Protein Society"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1126\/science.290.5493.985","article-title":"Oxidative damage linked to neurodegeneration by selective \u03b1-Synuclein nitration in Synucleinopathy lesions","volume":"290","author":"Giasson","year":"2000","journal-title":"Science"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1074\/jbc.M008919200","article-title":"A hydrophobic stretch of 12 amino acid residues in the middle of \u03b1-Synuclein is essential for filament assembly","volume":"276","author":"Giasson","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/hmg\/ddu520","article-title":"Potentiation of neurotoxicity in double-mutant mice with Pink1 ablation and A53T-SNCA overexpression","volume":"24","author":"Gispert","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/35081564","article-title":"Alpha-synuclein and neurodegenerative diseases","volume":"2","author":"Goedert","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1126\/science.1255555","article-title":"Alzheimer\u2019s and Parkinson\u2019s diseases: the prion concept in relation to assembled A\u03b2, tau, and \u03b1-synuclein","volume":"349","author":"Goedert","year":"2015","journal-title":"Science"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.3233\/JPD-179005","article-title":"The Synucleinopathies: twenty years on","volume":"7","author":"Goedert","year":"2017","journal-title":"J. Parkinsons Dis."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/jnc.14721","article-title":"Effects of alpha-synuclein post-translational modifications on metal binding","volume":"150","author":"Gonz\u00e1lez","year":"2019","journal-title":"J. Neurochem."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41586-022-05138-6","article-title":"Capillary forces generated by biomolecular condensates","volume":"609","author":"Gouveia","year":"2022","journal-title":"Nature"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1124\/PHARMREV.120.000133","article-title":"Therapeutics in the pipeline Targeting \u03b1-Synuclein for Parkinson's disease","volume":"74","author":"Grosso Jasutkar","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40478-018-0508-2","article-title":"Rapid and ultra-sensitive quantitation of disease-associated \u03b1-synuclein seeds in brain and cerebrospinal fluid by \u03b1Syn RT-QuIC","volume":"6","author":"Groveman","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.48907","article-title":"Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy","volume":"8","author":"Guerrero-Ferreira","year":"2019","journal-title":"eLife"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax0091","article-title":"Amyloid-like oligomerization of AIMP2 contributes to \u03b1-synuclein interaction and Lewy-like inclusion","volume":"12","author":"Ham","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1039\/d4cc01591f","article-title":"Aggregation and phase separation of \u03b1-synuclein in Parkinson's disease","volume":"60","author":"Han","year":"2024","journal-title":"Chem. Commun. (Camb.)"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/jmcb\/mjaa075","article-title":"Observation of an \u03b1-synuclein liquid droplet state and its maturation into Lewy body-like assemblies","volume":"13","author":"Hardenberg","year":"2021","journal-title":"J. Mol. Cell Biol."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"102822","DOI":"10.1016\/j.jbc.2022.102822","article-title":"Elucidation of ubiquitin-conjugating enzymes that interact with RBR-type ubiquitin ligases using a liquid\u2013liquid phase separation\u2013based method","volume":"299","author":"Hayashida","year":"2023","journal-title":"J. Biol. Chem."},{"key":"ref90","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1021\/acschemneuro.8b00288","article-title":"Alpha-Synuclein nitration and its implications in Parkinson\u2019s disease","volume":"10","author":"He","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.abb.2007.03.042","article-title":"DNA induces folding in \u03b1-synuclein: understanding the mechanism using chaperone property of osmolytes","volume":"464","author":"Hegde","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"key":"ref92","doi-asserted-by":"publisher","first-page":"15871","DOI":"10.1073\/pnas.0506109102","article-title":"Molecular-level secondary structure, polymorphism, and dynamics of full-length \u03b1-synuclein fibrils studied by solid-state NMR","volume":"102","author":"Heise","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"47746","DOI":"10.1074\/jbc.M408906200","article-title":"Functional consequences of \u03b1-Synuclein tyrosine nitration","volume":"279","author":"Hodara","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref94","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00401-022-02403-w","article-title":"Consequences of variability in \u03b1-synuclein fibril structure on strain biology","volume":"143","author":"Holec","year":"2022","journal-title":"Acta Neuropathol."},{"key":"ref95","doi-asserted-by":"publisher","first-page":"E3138","DOI":"10.1073\/pnas.1301440110","article-title":"Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds","volume":"110","author":"Holmes","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jmb.2008.08.039","article-title":"Structural characteristics of \u03b1-Synuclein oligomers stabilized by the flavonoid Baicalein","volume":"383","author":"Hong","year":"2008","journal-title":"J. Mol. Biol."},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1250532","article-title":"Liquid-liquid phase separation regulates alpha-synuclein aggregate and mitophagy in Parkinson\u2019s disease","volume":"17","author":"Hou","year":"2023","journal-title":"Front. Neurosci."},{"key":"ref98","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bbrc.2022.02.097","article-title":"Calcium promotes \u03b1-synuclein liquid-liquid phase separation to accelerate amyloid aggregation","volume":"603","author":"Huang","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref99","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","article-title":"Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis","volume":"16","author":"Irwin","year":"2017","journal-title":"The Lancet Neurology"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"106507","DOI":"10.1016\/j.bpc.2020.106507","article-title":"Biophysical processes underlying cross-seeding in amyloid aggregation and implications in amyloid pathology","volume":"269","author":"Ivanova","year":"2021","journal-title":"Biophys. Chem."},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158338","article-title":"The prion-like spreading of alpha-Synuclein in Parkinson's disease: update on models and hypotheses","volume":"22","author":"Jan","year":"2021","journal-title":"IJMS"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"19666","DOI":"10.1073\/pnas.0807826105","article-title":"Structure of membrane-bound \u03b1-synuclein from site-directed spin labeling and computational refinement","volume":"105","author":"Jao","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref103","doi-asserted-by":"publisher","first-page":"276","DOI":"10.21307\/ane-2019-026","article-title":"The interplay between parkin and alpha-synuclein; possible implications for the pathogenesis of parkinson\u2019s disease","volume":"79","author":"J\u0119\u015bko","year":"2019","journal-title":"Acta Neurobiol. Exp."},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax8891","article-title":"PARIS farnesylation prevents neurodegeneration in models of Parkinson\u2019s disease","volume":"13","author":"Jo","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat8407","article-title":"Poly(ADP-ribose) drives pathologic \u03b1-synuclein neurodegeneration in Parkinson\u2019s disease","volume":"362","author":"Kam","year":"2018","journal-title":"Science"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1038\/s41467-020-16580-3","article-title":"Liquid-liquid phase separation induces pathogenic tau conformations in vitro","volume":"11","author":"Kanaan","year":"2020","journal-title":"Nat. Commun."},{"key":"ref107","doi-asserted-by":"publisher","first-page":"e56166","DOI":"10.15252\/embr.202256166","article-title":"PARISundergoes liquid\u2013liquid phase separation and poly(ADP\u2010ribose)\u2010mediated solidification","volume":"24","author":"Kang","year":"2023","journal-title":"EMBO Rep."},{"key":"ref108","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1038\/emboj.2009.257","article-title":"Pre-fibrillar \u03b1-synuclein variants with impaired \u03b2-structure increase neurotoxicity in Parkinson\u2019s disease models","volume":"28","author":"Karpinar","year":"2009","journal-title":"EMBO J."},{"key":"ref109","doi-asserted-by":"publisher","first-page":"105654","DOI":"10.1016\/j.nbd.2022.105654","article-title":"Upregulation of \u03b1-synuclein following immune activation: possible trigger of Parkinson\u2019s disease","volume":"166","author":"Kasen","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"ref110","doi-asserted-by":"publisher","first-page":"e1006563","DOI":"10.1371\/journal.ppat.1006563","article-title":"Cross-seeding of prions by aggregated \u03b1-synuclein leads to transmissible spongiform encephalopathy","volume":"13","author":"Katorcha","year":"2017","journal-title":"PLoS Pathog."},{"key":"ref111","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.neuint.2008.08.004","article-title":"\u03b1-Synuclein enhances secretion and toxicity of amyloid beta peptides in PC12 cells","volume":"53","author":"Kazmierczak","year":"2008","journal-title":"Neurochem. Int."},{"key":"ref112","doi-asserted-by":"publisher","first-page":"e1011920","DOI":"10.1371\/journal.ppat.1011920","article-title":"The role of \u03b1-synuclein prion strains in Parkinson\u2019s disease and multiple system atrophy","volume":"20","author":"Khedmatgozar","year":"2024","journal-title":"PLoS Pathog."},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2114405119","article-title":"In situ proximity labeling identifies Lewy pathology molecular interactions in the human brain","volume":"119","author":"Killinger","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref114","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-021-00501-z","article-title":"Neuropathology and molecular diagnosis of Synucleinopathies","volume":"16","author":"Koga","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"ref115","doi-asserted-by":"publisher","first-page":"4760","DOI":"10.1038\/s41467-019-12683-8","article-title":"Cryo-EM structure and polymorphism of A\u03b2 amyloid fibrils purified from Alzheimer\u2019s brain tissue","volume":"10","author":"Kollmer","year":"2019","journal-title":"Nat. Commun."},{"key":"ref116","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1523\/JNEUROSCI.4564-06.2007","article-title":"Presynaptic \u03b1-Synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies","volume":"27","author":"Kramer","year":"2007","journal-title":"J. Neurosci."},{"key":"ref117","doi-asserted-by":"publisher","first-page":"e38099","DOI":"10.1371\/journal.pone.0038099","article-title":"Effect of spermidine on Misfolding and interactions of alpha-Synuclein","volume":"7","author":"Krasnoslobodtsev","year":"2012","journal-title":"PLoS One"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1083\/jcb.201010117","article-title":"Sumoylation inhibits \u03b1-synuclein aggregation and toxicity","volume":"194","author":"Krumova","year":"2011","journal-title":"J. Cell Biol."},{"key":"ref119","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41419-021-04046-3","article-title":"Differential mitochondrial roles for \u03b1-synuclein in DRP1-dependent fission and PINK1\/Parkin-mediated oxidation","volume":"12","author":"Krzystek","year":"2021","journal-title":"Cell Death Disease"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"101971","DOI":"10.1016\/j.npep.2019.101971","article-title":"A\u03b2, tau, and \u03b1-Synuclein aggregation and integrated role of PARK2 in the regulation and clearance of toxic peptides","volume":"78","author":"Kumar","year":"2019","journal-title":"Neuropeptides"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13024-020-00380-w","article-title":"Two C-terminal sequence variations determine differential neurotoxicity between human and mouse \u03b1-synuclein","volume":"15","author":"Landeck","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"ref122","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa2203395","article-title":"Trial of cinpanemab in early Parkinson\u2019s disease","volume":"387","author":"Lang","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref123","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of \u03b1-synuclein: from structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"ref124","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S0022-2836(02)00735-0","article-title":"\u03b1-Synuclein, especially the Parkinson\u2019s disease-associated mutants, forms pore-like annular and tubular Protofibrils","volume":"322","author":"Lashuel","year":"2002","journal-title":"J. Mol. Biol."},{"key":"ref125","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41593-019-0541-x","article-title":"\u03b1-Synuclein strains target distinct brain regions and cell types","volume":"23","author":"Lau","year":"2020","journal-title":"Nat. Neurosci."},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03111-4","article-title":"C-terminal calcium binding of \u03b1-synuclein modulates synaptic vesicle interaction. Nature","volume":"9","author":"Lautenschl\u00e4ger","year":"2018","journal-title":"Communications"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.92775.1","article-title":"Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles","author":"Lee","year":"2024","journal-title":"eLife."},{"key":"ref128","doi-asserted-by":"publisher","first-page":"7494","DOI":"10.1021\/acs.nanolett.8b02916","article-title":"Mapping surface hydrophobicity of \u03b1-Synuclein oligomers at the nanoscale","volume":"18","author":"Lee","year":"2018","journal-title":"Nano Lett."},{"key":"ref129","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neuron.2006.09.026","article-title":"Mechanisms of Parkinson\u2019s disease linked to pathological \u03b1-Synuclein: new targets for drug discovery","volume":"52","author":"Lee","year":"2006","journal-title":"Neuron"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1038\/s41467-018-05971-2","article-title":"Cryo-EM of full-length \u03b1-synuclein reveals fibril polymorphs with a common structural kernel","volume":"9","author":"Li","year":"","journal-title":"Nat. Commun."},{"key":"ref131","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3390\/foods13091287","article-title":"Curcumin inhibits \u03b1-Synuclein aggregation by acting on liquid-liquid phase transition","volume":"13","author":"Li","year":"2024","journal-title":"Foods"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"994","DOI":"10.3390\/biom12070994","article-title":"\u03b1-Synuclein conformational plasticity: physiologic states, pathologic strains, and biotechnological applications","volume":"12","author":"Li","year":"2022","journal-title":"Biomol. Ther."},{"key":"ref133","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1073\/pnas.0406976102","article-title":"Aggregation promoting C-terminal truncation of \u03b1-synuclein is a normal cellular process and is enhanced by the familial Parkinson\u2019s disease-linked mutations","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref134","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/s41422-018-0075-x","article-title":"Amyloid fibril structure of \u03b1-synuclein determined by cryo-electron microscopy","volume":"28","author":"Li","year":"","journal-title":"Cell Res."},{"key":"ref135","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40035-021-00242-5","article-title":"Differential seeding and propagating efficiency of \u03b1-synuclein strains generated in different conditions","volume":"10","author":"Liu","year":"2021","journal-title":"Transl. Neurodegen."},{"key":"ref136","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3390\/cells8070712","article-title":"Mitophagy in Parkinson\u2019s disease: from pathogenesis to treatment","volume":"8","author":"Liu","year":"2019","journal-title":"Cells"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2012435118","article-title":"Wild-type \u03b1-synuclein inherits the structure and exacerbated neuropathology of E46K mutant fibril strain by cross-seeding","volume":"118","author":"Long","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref138","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/2211-5463.13110","article-title":"Seeded assembly in vitro does not replicate the structures of \u03b1-synuclein filaments from multiple system atrophy","volume":"11","author":"L\u00f6vestam","year":"2021","journal-title":"FEBS Open Bio."},{"key":"ref139","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1073\/pnas.1913904117","article-title":"The process of Lewy body formation, rather than simply \u03b1-synuclein fibrillization, is one of the major drivers of neurodegeneration","volume":"117","author":"Mahul-Mellier","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref141","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.tibs.2020.11.007","article-title":"Mitochondrial dysfunction and Mitophagy in Parkinson\u2019s disease: from mechanism to therapy","volume":"46","author":"Malpartida","year":"2021","journal-title":"Trends Biochem. Sci."},{"key":"ref142","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s40478-021-01288-2","article-title":"Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro","volume":"9","author":"Marotta","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"ref143","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40035-022-00283-4","article-title":"Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy","volume":"11","author":"Martinez-Valbuena","year":"2022","journal-title":"Transl. Neurodegen."},{"key":"ref144","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awt037","article-title":"Prion-like spreading of pathological \u03b1-synuclein in brain","volume":"136","author":"Masuda-Suzukake","year":"2013","journal-title":"Brain"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1474-9726.2007.00275.x","article-title":"Calcium and neurodegeneration","volume":"6","author":"Mattson","year":"2007","journal-title":"Aging Cell"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3233\/JPD-239901","article-title":"Parkinson's disease drug therapies in the clinical trial pipeline: 2023 update","volume":"13","author":"McFarthing","year":"2023","journal-title":"J. Parkinsons Dis."},{"key":"ref147","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.molcel.2018.07.002","article-title":"Poly (ADP-ribose) prevents pathological phase separation of TDP-43 by promoting liquid Demixing and stress granule localization","volume":"71","author":"McGurk","year":"2018","journal-title":"Mol. Cell"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-019-0329-1","article-title":"Alpha-synuclein structure and Parkinson\u2019s disease - lessons and emerging principles","volume":"14","author":"Meade","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref149","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.4103\/1673-5374.235013","article-title":"Subcellular localization of alpha-synuclein aggregates and their interaction with membranes","volume":"13","author":"Miraglia","year":"2018","journal-title":"Neural. Regen. Res."},{"key":"ref150","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41573-022-00505-4","article-title":"Modulating biomolecular condensates: a novel approach to drug discovery","volume":"21","author":"Mitrea","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref151","doi-asserted-by":"publisher","first-page":"167713","DOI":"10.1016\/j.jmb.2022.167713","article-title":"Liquid-liquid phase separation of \u03b1-Synuclein: a new mechanistic insight for \u03b1-Synuclein aggregation associated with Parkinson\u2019s disease pathogenesis","volume":"435","author":"Mukherjee","year":"2023","journal-title":"J. Mol. Biol."},{"key":"ref152","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.703984","article-title":"Development of \u03b1-Synuclein real-time quaking-induced conversion as a diagnostic method for \u03b1-Synucleinopathies","volume":"13","author":"Nakagaki","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref153","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202004062","article-title":"Liquid\u2013liquid phase separation in autophagy","volume":"219","author":"Noda","year":"2020","journal-title":"J. Cell Biol."},{"key":"ref154","doi-asserted-by":"publisher","first-page":"140943","DOI":"10.1016\/j.bbapap.2023.140943","article-title":"Antibodies and \u03b1-synuclein: what to target against Parkinson's disease?","volume":"1872","author":"Otzen","year":"2024","journal-title":"Proteins Proteomics"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1056\/NEJMoa2202867","article-title":"Trial of prasinezumab in early-stage Parkinson\u2019s disease","volume":"387","author":"Pagano","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref156","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.cell.2015.07.047","article-title":"A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation","volume":"162","author":"Patel","year":"2015","journal-title":"Cell"},{"key":"ref157","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00441-018-2839-5","article-title":"\u0251-Synuclein strains and seeding in Parkinson\u2019s disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences","volume":"373","author":"Peelaerts","year":"2018","journal-title":"Cell Tissue Res."},{"key":"ref158","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature14547","article-title":"\u03b1-Synuclein strains cause distinct synucleinopathies after local and systemic administration","volume":"522","author":"Peelaerts","year":"2015","journal-title":"Nature"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","article-title":"Cellular milieu imparts distinct pathological \u03b1-synuclein strains in \u03b1-synucleinopathies","volume":"557","author":"Peng","year":"","journal-title":"Nature"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.nbd.2017.07.018","article-title":"Distinct \u03b1-Synuclein strains and implications for heterogeneity among \u03b1-Synucleinopathies","volume":"109","author":"Peng","year":"","journal-title":"Neurobiol. Dis."},{"key":"ref161","first-page":"3766","article-title":"Liquid-liquid phase separation (LLPS) in cellular physiology and tumor biology","volume":"11","author":"Peng","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"ref162","doi-asserted-by":"publisher","first-page":"E1009","DOI":"10.1073\/pnas.1610586114","article-title":"A natural product inhibits the initiation of \u03b1-synuclein aggregation and suppresses its toxicity","volume":"114","author":"Perni","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13024-020-00363-x","article-title":"PARIS induced defects in mitochondrial biogenesis drive dopamine neuron loss under conditions of parkin or PINK1 deficiency","volume":"15","author":"Pirooznia","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"ref164","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg5663","article-title":"\u03b1-Synuclein liquid condensates fuel fibrillar \u03b1-synuclein growth","volume":"9","author":"Piroska","year":"2023","journal-title":"Advances"},{"key":"ref165","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3233\/JPD-212594","article-title":"Safety and tolerability of active immunotherapy targeting \u03b1-Synuclein with PD03A in patients with early Parkinson's disease: a randomized, placebo-controlled, phase 1 study","volume":"11","author":"Poewe","year":"2021","journal-title":"J. Parkinsons Dis."},{"key":"ref166","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1074\/jbc.M114.610527","article-title":"The H50Q mutation induces a 10-fold decrease in the solubility of \u03b1-Synuclein","volume":"290","author":"Porcari","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref167","first-page":"831","article-title":"The neuropathology of genetic Parkinson\u2019s disease. In movement disorders.","volume-title":"Movem. Dis. Official J. Movem. Dis. Soc.","author":"Poulopoulos","year":"2012"},{"key":"ref168","doi-asserted-by":"publisher","first-page":"16165","DOI":"10.1038\/s41598-018-34490-9","article-title":"The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease","volume":"8","author":"Price","year":"2018","journal-title":"Sci. Rep."},{"key":"ref169","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1038\/s41598-023-29846-9","article-title":"Initiation and modulation of tau protein phase separation by the drug suramin","volume":"13","author":"Prince","year":"2023","journal-title":"Sci. Rep."},{"key":"ref170","doi-asserted-by":"publisher","first-page":"18841","DOI":"10.1039\/d2cp02042d","article-title":"Molecular dynamics simulations of an \u03b1-synuclein NAC domain fragment with a ff14IDPSFF IDP-specific force field suggest \u03b2-sheet intermediate states of fibrillation","volume":"24","author":"Privat","year":"2022","journal-title":"Phys. Chem. Chem. Phys."},{"key":"ref171","doi-asserted-by":"publisher","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","article-title":"Evidence for \u03b1-synuclein prions causing multiple system atrophy in humans with parkinsonism","volume":"112","author":"Prusiner","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref172","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.704041","article-title":"Poly (ADP-ribose) interacts with phosphorylated \u03b1-Synuclein in post mortem PD samples","volume":"13","author":"Puentes","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref173","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41557-020-0465-9","article-title":"\u03b1-Synuclein aggregation nucleates through liquid\u2013liquid phase separation","volume":"12","author":"Ray","year":"2020","journal-title":"Nat. Chem."},{"key":"ref174","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s40478-019-0859-3","article-title":"\u03b1-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb","volume":"7","author":"Rey","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"ref175","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1093\/brain\/awy146","article-title":"Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated","volume":"141","author":"Robinson","year":"2018","journal-title":"Brain"},{"key":"ref176","doi-asserted-by":"publisher","first-page":"41051","DOI":"10.1038\/srep41051","article-title":"Evidence for intramolecular antiparallel Beta-sheet structure in alpha-Synuclein fibrils from a combination of two-dimensional infrared spectroscopy and atomic force microscopy","volume":"7","author":"Roeters","year":"2017","journal-title":"Sci. Rep."},{"key":"ref177","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2313465121","article-title":"Modulation of \u03b1-synuclein in vitro aggregation kinetics by its alternative splice isoforms","volume":"121","author":"R\u00f6ntgen","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref178","doi-asserted-by":"publisher","first-page":"13176","DOI":"10.1073\/pnas.1704351114","article-title":"SUMOylation and ubiquitination reciprocally regulate \u03b1-synuclein degradation and pathological aggregation","volume":"114","author":"Rott","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref179","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1021\/acs.biochem.1c00434","article-title":"Modulating \u03b1-Synuclein liquid\u2013liquid phase separation","volume":"60","author":"Sawner","year":"2021","journal-title":"Biochemistry"},{"key":"ref180","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.tins.2014.03.004","article-title":"Parkin and PINK1: much more than mitophagy","volume":"37","author":"Scarffe","year":"2014","journal-title":"Trends Neurosci."},{"key":"ref181","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.4049\/jimmunol.2100035","article-title":"Microglial NLRP3 Inflammasome activation upon TLR2 and TLR5 ligation by distinct \u03b1-Synuclein assemblies","volume":"207","author":"Scheiblich","year":"2021","journal-title":"J. Immunol."},{"key":"ref182","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","article-title":"Structures of \u03b1-synuclein filaments from multiple system atrophy","volume":"585","author":"Schweighauser","year":"2020","journal-title":"Nature"},{"key":"ref183","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1007\/s12035-021-02596-3","article-title":"An update on the critical role of \u03b1-Synuclein in Parkinson\u2019s disease and other Synucleinopathies: from tissue to cellular and molecular levels","volume":"59","author":"Serratos","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"ref184","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","article-title":"Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes","volume":"22","author":"Shahmoradian","year":"2019","journal-title":"Nat. Neurosci."},{"key":"ref185","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","article-title":"Discriminating \u03b1-synuclein strains in Parkinson\u2019s disease and multiple system atrophy","volume":"578","author":"Shahnawaz","year":"2020","journal-title":"Nature"},{"key":"ref186","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0896-6273(03)00024-2","article-title":"The formation of highly soluble oligomers of \u03b1-Synuclein is regulated by fatty acids and enhanced in Parkinson\u2019s disease","volume":"37","author":"Sharon","year":"2003","journal-title":"Neuron"},{"key":"ref187","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.bpj.2020.01.022","article-title":"Differential membrane binding and seeding of distinct \u03b1-Synuclein Fibrillar polymorphs","volume":"118","author":"Shrivastava","year":"2020","journal-title":"Biophys. J."},{"key":"ref188","doi-asserted-by":"publisher","first-page":"12833","DOI":"10.1523\/JNEUROSCI.0109-15.2015","article-title":"Mitochondrial quality control via the PGC1\u03b1-TFEB signaling pathway is compromised by Parkin Q311X mutation but independently restored by rapamycin","volume":"35","author":"Siddiqui","year":"2015","journal-title":"J. Neurosci."},{"key":"ref189","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.nbd.2016.05.009","article-title":"Detrimental effects of oxidative losses in parkin activity in a model of sporadic Parkinson\u2019s disease are attenuated by restoration of PGC1alpha","volume":"93","author":"Siddiqui","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref190","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/mds.29170","article-title":"Phase 1\/1b studies of UCB0599, an Oral inhibitor of \u03b1-Synuclein Misfolding, including a randomized study in Parkinson's disease","volume":"37","author":"Smit","year":"2022","journal-title":"Movement Disord."},{"key":"ref191","article-title":"SNCA gene: MedlinePlus Genetics","year":"2021"},{"key":"ref192","doi-asserted-by":"publisher","first-page":"168011","DOI":"10.1016\/j.jmb.2023.168011","article-title":"\u03b1-Synuclein conformational strains as drivers of phenotypic heterogeneity in neurodegenerative diseases","volume":"435","author":"So","year":"2023","journal-title":"J. Mol. Biol."},{"key":"ref193","doi-asserted-by":"publisher","first-page":"18914","DOI":"10.1074\/jbc.RA118.005603","article-title":"Physiological C-terminal truncation of \u03b1-synuclein potentiates the prion-like formation of pathological inclusions","volume":"293","author":"Sorrentino","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref194","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","article-title":"\u03b1-Synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"ref195","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3390\/biom11071014","article-title":"Prion-like proteins in phase separation and their link to disease","volume":"11","author":"Sprunger","year":"2021","journal-title":"Biomol. Ther."},{"key":"ref196","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s42004-020-00412-y","article-title":"Screening of small molecules using the inhibition of oligomer formation in \u03b1-synuclein aggregation as a selection parameter","volume":"3","author":"Staats","year":"2020","journal-title":"Commun. Chem."},{"key":"ref197","doi-asserted-by":"publisher","first-page":"6975","DOI":"10.1021\/acs.analchem.8b01264","article-title":"Different structural conformers of monomeric \u03b1-Synuclein identified after lyophilizing and freezing","volume":"90","author":"Stephens","year":"2018","journal-title":"Anal. Chem."},{"key":"ref198","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.tibs.2018.11.005","article-title":"The cellular environment affects monomeric \u03b1-Synuclein structure","volume":"44","author":"Stephens","year":"2019","journal-title":"Trends Biochem. Sci."},{"key":"ref199","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1038\/s41467-020-16564-3","article-title":"Extent of N-terminus exposure of monomeric alpha-synuclein determines its aggregation propensity","volume":"11","author":"Stephens","year":"2020","journal-title":"Nat. Commun."},{"key":"ref200","doi-asserted-by":"publisher","first-page":"11696","DOI":"10.1073\/pnas.1500624112","article-title":"Parkin loss leads to PARIS-dependent declines in mitochondrial mass and respiration","volume":"112","author":"Stevens","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref201","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1093\/hmg\/ddm083","article-title":"Mono- and double-mutant mouse models of Parkinson\u2019s disease display severe mitochondrial damage","volume":"16","author":"Stichel","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"ref202","doi-asserted-by":"publisher","first-page":"105345","DOI":"10.1016\/j.neuint.2022.105345","article-title":"Evolution of \u03b1-synuclein conformation ensemble toward amyloid fibril via liquid-liquid phase separation (LLPS) as investigated by dynamic nuclear polarization-enhanced solid-state MAS NMR","volume":"157","author":"Takamuku","year":"2022","journal-title":"Neurochem. Int."},{"key":"ref203","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40478-018-0532-2","article-title":"Potent prion-like behaviors of pathogenic \u03b1-synuclein and evaluation of inactivation methods","volume":"6","author":"Tarutani","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"ref204","doi-asserted-by":"publisher","first-page":"E8284","DOI":"10.1073\/pnas.1710442114","article-title":"Modeling Parkinson\u2019s disease pathology by combination of fibril seeds and \u03b1-synuclein overexpression in the rat brain","volume":"114","author":"Thakur","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref205","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nature16531","article-title":"Structural disorder of monomeric \u03b1-synuclein persists in mammalian cells","volume":"530","author":"Theillet","year":"2016","journal-title":"Nature"},{"key":"ref206","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1139\/G08-085","article-title":"Pink1suppresses\u03b1-synuclein-induced phenotypes in aDrosophilamodel of Parkinson\u2019s disease","volume":"51","author":"Todd","year":"2008","journal-title":"Genome"},{"key":"ref207","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/j.1742-4658.2012.08489.x","article-title":"Role of \u03b1-synuclein penetration into the membrane in the mechanisms of oligomer pore formation","volume":"279","author":"Tsigelny","year":"2012","journal-title":"FEBS J."},{"key":"ref208","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nsmb.3194","article-title":"Solid-state NMR structure of a pathogenic fibril of full-length human \u03b1-synuclein","volume":"23","author":"Tuttle","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref209","doi-asserted-by":"publisher","first-page":"e202205726","DOI":"10.1002\/anie.202205726","article-title":"Direct observation of \u201celongated\u201d conformational states in \u03b1-Synuclein upon liquid-liquid phase separation","volume":"61","author":"Ubbiali","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref210","doi-asserted-by":"publisher","first-page":"6892","DOI":"10.1038\/s41467-023-42705-5","article-title":"\u03b1-Synuclein aggregates amplified from patient-derived Lewy bodies recapitulate Lewy body diseases in mice","volume":"14","author":"Uemura","year":"2023","journal-title":"Nat. Commun."},{"key":"ref211","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.040899","article-title":"Misfolded \u03b1-synuclein causes hyperactive respiration without functional deficit in live neuroblastoma cells","volume":"13","author":"Ugalde","year":"2020","journal-title":"Dis. Model. Mech."},{"key":"ref212","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/jnc.13772","article-title":"Pathogenic mechanisms of prion protein, amyloid-\u03b2 and \u03b1-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers","volume":"139","author":"Ugalde","year":"2016","journal-title":"J. Neurochem."},{"key":"ref213","doi-asserted-by":"publisher","first-page":"9016","DOI":"10.1074\/jbc.REV119.007500","article-title":"The role of lipids in \u03b1-synuclein misfolding and neurotoxicity","volume":"294","author":"Ugalde","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref214","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.bbadis.2008.07.004","article-title":"Impact of Tyr to ala mutations on \u03b1-synuclein fibrillation and structural properties","volume":"1782","author":"Ulrih","year":"2008","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"ref9001","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32940-7","article-title":"Protein condensation diseases: therapeutic opportunities","volume":"13","author":"Vendruscolo","year":"2022","journal-title":"Nature communications"},{"key":"ref215","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00388","article-title":"The close encounter between alpha-synuclein and mitochondria","volume":"12","author":"Vicario","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref216","doi-asserted-by":"publisher","DOI":"10.3390\/cells11111732","article-title":"Alpha-Synuclein aggregation pathway in Parkinson\u2019s disease: current status and novel therapeutic approaches","volume":"11","author":"Vidovi\u0107","year":"2022","journal-title":"Cells"},{"key":"ref217","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S1474-4422(20)30136-8","article-title":"Safety and immunogenicity of the \u03b1-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial","volume":"19","author":"Volc","year":"2020","journal-title":"Lancet. Neurol."},{"key":"ref218","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1091\/mbc.e14-02-0741","article-title":"Formation of \u03b1-synuclein Lewy neurite\u2013like aggregates in axons impedes the transport of distinct endosomes","volume":"25","author":"Volpicelli-Daley","year":"2014","journal-title":"Mol. Biol. Cell"},{"key":"ref219","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","article-title":"Exogenous \u03b1-Synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death","volume":"72","author":"Volpicelli-Daley","year":"2011","journal-title":"Neuron"},{"key":"ref220","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00401-013-1114-9","article-title":"Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease","volume":"125","author":"Wagner","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref221","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41392-021-00678-1","article-title":"Liquid\u2013liquid phase separation in human health and diseases","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref222","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2016.00048","article-title":"Versatile structures of \u03b1-Synuclein","volume":"9","author":"Wang","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"ref223","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201798049","article-title":"Tau protein liquid\u2013liquid phase separation can initiate tau aggregation","volume":"37","author":"Wegmann","year":"2018","journal-title":"EMBO J."},{"key":"ref224","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.591475","article-title":"Exogenous alpha-Synuclein evoked Parkin downregulation promotes mitochondrial dysfunction in neuronal cells. Implications for Parkinson's disease pathology","volume":"13","author":"Wilkaniec","year":"2021","journal-title":"Neuroscience"},{"key":"ref225","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12035-018-1082-0","article-title":"Extracellular alpha-Synuclein oligomers induce Parkin S-Nitrosylation: relevance to sporadic Parkinson\u2019s disease Etiopathology","volume":"56","author":"Wilkaniec","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"ref226","doi-asserted-by":"publisher","first-page":"16906","DOI":"10.1523\/JNEUROSCI.2723-12.2012","article-title":"Role of \u03b1-Synuclein in adult neurogenesis and neuronal maturation in the dentate gyrus","volume":"32","author":"Winner","year":"2012","journal-title":"J. Neurosci."},{"key":"ref227","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1021\/cn3002027","article-title":"Structures of the E46K mutant-type \u03b1-Synuclein protein and impact of E46K mutation on the structures of the wild-type \u03b1-Synuclein protein","volume":"4","author":"Wise-Scira","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"ref228","doi-asserted-by":"publisher","first-page":"E4949","DOI":"10.1073\/pnas.1513426112","article-title":"Propagation of prions causing synucleinopathies in cultured cells","volume":"112","author":"Woerman","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref229","doi-asserted-by":"publisher","first-page":"13199","DOI":"10.3390\/ijms241713199","article-title":"Beyond strains: molecular diversity in alpha-Synuclein at the Center of Disease Heterogeneity","volume":"24","author":"Wojewska","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"ref230","doi-asserted-by":"publisher","first-page":"19509","DOI":"10.1074\/jbc.274.28.19509","article-title":"\u03b1-Synuclein Fibrillogenesis is nucleation-dependent","volume":"274","author":"Wood","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref231","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1016\/j.neuron.2021.04.021","article-title":"Membraneless condensates by Rapsn phase separation as a platform for neuromuscular junction formation","volume":"109","author":"Xing","year":"2021","journal-title":"Neuron"},{"key":"ref232","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3390\/molecules27041293","article-title":"The pathological G51D mutation in alpha-Synuclein oligomers confers distinct structural attributes and cellular toxicity","volume":"27","author":"Xu","year":"2022","journal-title":"Molecules"},{"key":"ref233","doi-asserted-by":"publisher","first-page":"30281","DOI":"10.1021\/acsomega.2c03534","article-title":"Curcumin interacts with \u03b1-Synuclein condensates to inhibit amyloid aggregation under phase separation","volume":"7","author":"Xu","year":"","journal-title":"ACS Omega"},{"key":"ref234","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3390\/biom13050726","article-title":"Distinct effects of familial Parkinson\u2019s disease-associated mutations on \u03b1-Synuclein phase separation and amyloid aggregation","volume":"13","author":"Xu","year":"2023","journal-title":"Biomol. Ther."},{"key":"ref235","doi-asserted-by":"publisher","first-page":"101469","DOI":"10.1016\/j.jbc.2021.101469","article-title":"Manganese promotes \u03b1-synuclein amyloid aggregation through the induction of protein phase transition","volume":"298","author":"Xu","year":"","journal-title":"J. Biol. Chem."},{"key":"ref236","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.molcel.2019.12.026","article-title":"Liquidity is a critical determinant for selective autophagy of protein condensates","volume":"77","author":"Yamasaki","year":"2020","journal-title":"Mol. Cell"},{"key":"ref237","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1074\/jbc.RA118.004471","article-title":"Parkinson\u2019s disease and multiple system atrophy have distinct \u03b1-synuclein seed characteristics","volume":"294","author":"Yamasaki","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref238","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41586-022-05319-3","article-title":"Structures of \u03b1-synuclein filaments from human brains with Lewy pathology","volume":"610","author":"Yang","year":"2022","journal-title":"Nature"},{"key":"ref239","doi-asserted-by":"publisher","first-page":"10810","DOI":"10.1073\/pnas.0404161101","article-title":"Nitrosative stress linked to sporadic Parkinson\u2019s disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity","volume":"101","author":"Yao","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref240","doi-asserted-by":"publisher","first-page":"323","DOI":"10.5483\/BMBRep.2022.55.7.073","article-title":"Role of post-translational modifications on the alpha-synuclein aggregation-related pathogenesis of Parkinson\u2019s disease","volume":"55","author":"Yoo","year":"2022","journal-title":"BMB Rep."},{"key":"ref241","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.devcel.2020.09.014","article-title":"Phase separation and neurodegenerative diseases: a disturbance in the force","volume":"55","author":"Zbinden","year":"2020","journal-title":"Dev. Cell"},{"key":"ref242","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-genet-022422-095608","article-title":"The genetics of autophagy in multicellular organisms","volume":"56","author":"Zhang","year":"2022","journal-title":"Annu. Rev. Genet."},{"key":"ref243","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.43584","article-title":"Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer\u2019s and Pick\u2019s diseases","volume":"8","author":"Zhang","year":"2019","journal-title":"eLife"},{"key":"ref244","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1038\/s41467-020-16386-3","article-title":"Parkinson\u2019s disease associated mutation E46K of \u03b1-synuclein triggers the formation of a distinct fibril structure","volume":"11","author":"Zhao","year":"2020","journal-title":"Nat. Commun."},{"key":"ref245","doi-asserted-by":"publisher","first-page":"167680","DOI":"10.1016\/j.jmb.2022.167680","article-title":"Structural insights of Fe3+ induced \u03b1-synuclein fibrillation in Parkinson\u2019s disease","volume":"435","author":"Zhao","year":"2023","journal-title":"J. Mol. Biol."},{"key":"ref246","doi-asserted-by":"publisher","DOI":"10.1111\/febs.17244","article-title":"Liquid-liquid phase separation of alpha-synuclein increases the structural variability of fibrils formed during amyloid aggregation","author":"Ziaunys","year":"2024","journal-title":"FEBS J."}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2024.1494218\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T05:12:07Z","timestamp":1729660327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2024.1494218\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"references-count":247,"alternative-id":["10.3389\/fnmol.2024.1494218"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2024.1494218","relation":{},"ISSN":["1662-5099"],"issn-type":[{"value":"1662-5099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,23]]},"article-number":"1494218"}}